Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.21 -0.48 (-3.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Accumulated Expenses (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) posted Accumulated Expenses of $22.85 million for Q2 2026, down 7.2% from $24.63 million a year earlier but up 0.8% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Arcturus Therapeutics Holdings' Accumulated Expenses came in at $23.9 million, down 38.4% from FY2024.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of 4.3% (FY2020 to FY2025).
  • In prior years, Arcturus Therapeutics Holdings' Accumulated Expenses was $38.78 million in FY2024 (+21.6%), $31.88 million in FY2023 (+5.5%), $30.23 million in FY2022 (+28.5%) and $23.52 million in FY2021 (+21.3%).
  • Quarterly Accumulated Expenses has run from a low of $19.38 million in Q3 2025 to a high of $52.36 million in Q3 2021 over five years.
  • On a year-over-year basis, Accumulated Expenses has declined in each of the last six quarters, with an average decline of 14.9% over the last eight quarters.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2021, with growth of 230.6%; the weakest was Q3 2022, with a decline of 51.2%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $22.67 million (Q1 2026), $23.9 million (Q4 2025) and $19.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Arcturus Therapeutics Holdings 389.11 Mn -425.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.85 Mn
Mar 31, 2026 22.67 Mn
Dec 31, 2025 23.90 Mn
Sep 30, 2025 19.38 Mn
Jun 30, 2025 24.63 Mn
Mar 31, 2025 30.56 Mn
Dec 31, 2024 38.78 Mn
Sep 30, 2024 32.40 Mn
Jun 30, 2024 35.45 Mn
Mar 31, 2024 34.77 Mn
Dec 31, 2023 31.88 Mn
Sep 30, 2023 28.55 Mn
Jun 30, 2023 28.76 Mn
Mar 31, 2023 32.29 Mn
Dec 31, 2022 30.23 Mn
Sep 30, 2022 25.53 Mn
Jun 30, 2022 33.61 Mn
Mar 31, 2022 19.97 Mn
Dec 31, 2021 23.52 Mn
Sep 30, 2021 52.36 Mn
API Access

Arcturus Therapeutics Holdings Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARCT&period=max&api_key=YOUR_API_KEY